These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3545736)

  • 1. Cibenzoline-induced hypoglycemia.
    Hilleman DE; Mohiuddin SM; Ahmed IS; Dahl JM
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):38-40. PubMed ID: 3545736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide.
    Takada M; Fujita S; Katayama Y; Harano Y; Shibakawa M
    Eur J Clin Pharmacol; 2000 Jul; 56(4):335-42. PubMed ID: 10954349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypoglycemia caused by overdose of a new anti-arrhythmia agent: cibenzoline. 3 cases].
    Lefort G; Haissaguerre M; Floro J; Beauffigeau P; Warin JF; Latapie JL
    Presse Med; 1988 Apr; 17(14):687-91. PubMed ID: 2966953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypoglycemia induced by cibenzoline in the elderly].
    Houdent C; Noblet C; Vandoren C; Levesque H; Morin C; Moore N; Courtois H; Wolf LM
    Rev Med Interne; 1991; 12(2):143-5. PubMed ID: 1852997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic effect of cibenzoline in patients with abnormal glucose tolerance and frequent ventricular arrhythmias.
    Saikawa T; Arita M; Yamaguchi K; Ito M
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):665-9. PubMed ID: 11300368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic Coma Induced by the Use of Succinic Acid Cibenzoline in Frail Late-stage Elderly Subjects.
    Hirata Y; Kamei S; Tatsumi F; Shimoda M; Tanabe A; Sanada J; Fushimi Y; Irie S; Mune T; Kaku K; Kaneto H
    Intern Med; 2017; 56(12):1527-1529. PubMed ID: 28626178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a direct stimulatory effect of cibenzoline on insulin secretion in rats.
    Bertrand G; Gross R; Petit P; Loubatières-Mariani MM; Ribes G
    Eur J Pharmacol; 1992 Apr; 214(2-3):159-63. PubMed ID: 1516637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of cibenzoline-induced hypoglycemia in rats.
    Takahashi Y; Ishiwata Y; Kojima Y; Yasuhara M
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):242-7. PubMed ID: 21273730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of therapeutic drug monitoring on the risk of hypoglycemia in HOCM patients on cibenzoline therapy
.
    Mukai Y; Wada K; Fujimoto M; Hosomi K; Kuwahara T; Takada M
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):795-803. PubMed ID: 27443663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and 4 properties, in patients with recurrent ventricular tachycardia.
    Cocco G; Strozzi C; Pansini R; Rochat N; Bulgarelli R; Padula A; Sfrisi C; Kamal Al Yassini A
    Eur Heart J; 1984 Feb; 5(2):108-14. PubMed ID: 6723683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypoglycemia caused by cibenzoline. Apropos of a new case].
    Noury JF; Delvaux JC
    Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):7-8. PubMed ID: 2648968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of therapeutic drug monitoring in prevention of hypoglycemia caused by cibenzoline.
    Takada M; Shibakawa M
    Eur J Clin Pharmacol; 2001 Dec; 57(10):695-700. PubMed ID: 11829197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline.
    Ishida-Takahashi A; Horie M; Tsuura Y; Ishida H; Ai T; Sasayama S
    Br J Pharmacol; 1996 Apr; 117(8):1749-55. PubMed ID: 8732286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.
    Hamada M; Ikeda S; Ohshima K; Nakamura M; Kubota N; Ogimoto A; Shigematsu Y
    J Cardiol; 2016 Mar; 67(3):279-86. PubMed ID: 26116980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of ATP sensitive potassium channels in heart and pancreatic beta cells using Vaughan-Williams class Ia antiarrhythmics.
    Horie M; Hayashi S; Yuzuki Y; Sasayama S
    Cardiovasc Res; 1992 Nov; 26(11):1087-94. PubMed ID: 1291086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic syncope induced by a combination of cibenzoline and angiotensin converting enzyme inhibitor.
    Ogimoto A; Hamada M; Saeki H; Hiasa G; Ohtsuka T; Hashida H; Hara Y; Okura T; Shigematsu Y; Hiwada K
    Jpn Heart J; 2001 Mar; 42(2):255-9. PubMed ID: 11384085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic hypoglycemia in a patient with chronic hemodialysis.
    Vandecandelaere P; Verbanck J; Matthys K; de Hoon J; Verbesselt R
    Acta Clin Belg; 2006; 61(5):249-51. PubMed ID: 17240739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term antiarrhythmic therapy with cibenzoline.
    Mohiuddin SM; Hilleman DE; Esterbrooks D; Mooss AN; Stengel LA
    J Clin Pharmacol; 1987; 27(5):400-6. PubMed ID: 3693585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
    Browne KF; Prystowsky EN; Zipes DP; Chilson DA; Heger JJ
    J Am Coll Cardiol; 1984 Mar; 3(3):857-64. PubMed ID: 6693656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.